The Patent Finder
US

Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin

US 8,236,796 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Nov 7, 2026 · High confidence

Filed Apr 2, 2009 as application 12/417,598 · Granted Aug 7, 2012
Base term plus 516 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
Term ended Nov 7, 2026
2005 2026
Clock starts
Jul 15, 2005
Term ended
Nov 7, 2026
Granted
Aug 7, 2012
base term patent term adjustment after the term ends fee events Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
516
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 7,541,357.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 516 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jul 15, 2005, when application 11/183,066, the earliest non-provisional in its chain, was filed (this one was filed Apr 2, 2009)Jul 15, 2025High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+516 days, USPTO patent term adjustment recordDec 13, 2026High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,541,357)capped to Nov 7, 2026High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderNov 7, 2026High confidence

This family

US 7,541,357Term ended
Nov 2026
Nov 2026
US 8,227,486Term ended
Nov 2026
Nov 2026
US 8,236,796this patent
Nov 2026
Nov 2026
US 8,741,901Term ended
Jul 2025
Jul 2025
US 9,085,531Term ended
no later than Jul 2025
no later than Jul 2025
US 9,499,531Term ended
Jul 2025
Jul 2025
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 6, 2011
Reel 26397, frame 1
Albany Molecular Research, Inc.; Amri Rensselaer, Inc.; Amri Bothell Research Center, Inc.; Amri Burlington, Inc.Bank of America, N.A., as Administrative AgentIntellectual Property Security Agreement
Apr 19, 2012
Reel 28072, frame 335
Bank Of America, N.a.Albany Molecular Research, Inc.; Amri Bothell Research Center, Inc.; Amri Burlington, Inc.; Amri Renesselaer, Inc.Termination
Apr 19, 2012
reel/frame not recorded
Bank Of America, N.a.Albany Molecular Research, Inc.Termination
Apr 19, 2012
reel/frame not recorded
Bank Of America, N.a.Amri Bothell Research Center, Inc.Termination
Apr 19, 2012
reel/frame not recorded
Bank Of America, N.a.Amri Burlington, Inc.Termination
Apr 19, 2012
reel/frame not recorded
Bank Of America, N.a.Amri Renesselaer, Inc.Termination
Apr 20, 2012
Reel 28078, frame 227
Albany Molecular Research, Inc.; Amri Burlington, Inc.; Amri Bothell Research Center, Inc.; Amri Renesselaer, Inc.Wells Fargo Bank, National AssociationSecurity Agreement
Jul 9, 2014
Reel 33283, frame 357
Wells FargoAlbany Molecular Research, Inc.Release of Security Interest
Oct 24, 2014
Reel 34045, frame 951
Albany Molecular Research, Inc.; Alo Acquisition LLC; Amri Burlington, Inc.; Amri Rensselaer, Inc.; Cedarburg Pharmaceuticals, Inc.; Oso Biopharmaceuticals Manufacturing, LLCBarclays Bank PLC, as the Collateral AgentSecurity Interest
Jun 22, 2016
Reel 39116, frame 827
Bristol-Myers Squibb CompanyAlbany Molecular Research, Inc.Assignment of Assignor's Interest
Aug 31, 2017
Reel 43742, frame 85
Barclays Bank PLC, as Collateral AgentAlbany Molecular Research, Inc.; Alo Acquisition LLC; Amri Burlington, Inc.; Amri Rensselaer, Inc.; Cedarburg Pharmaceuticals, Inc.; Oso Biopharmaceuticals Manufacturing, LLC; Amri Ssci, LLC; Euticals Inc.Release of Security Interest
Aug 31, 2017
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentAlbany Molecular Research, Inc.Release of Security Interest
Aug 31, 2017
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentAlo Acquisition LLCRelease of Security Interest
Aug 31, 2017
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentAmri Burlington, Inc.Release of Security Interest
Aug 31, 2017
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentAmri Rensselaer, Inc.Release of Security Interest
Aug 31, 2017
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentCedarburg Pharmaceuticals, Inc.Release of Security Interest
Aug 31, 2017
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentOso Biopharmaceuticals Manufacturing, LLCRelease of Security Interest
Aug 31, 2017
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentAmri Ssci, LLCRelease of Security Interest
Aug 31, 2017
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentEuticals Inc.Release of Security Interest
Sep 1, 2017
Reel 43746, frame 621
Albany Molecular Research, Inc.; Amri Burlington, Inc.; Cedarburg Pharmaceuticals, Inc.; Euticals Inc.; Oso Biopharmaceuticals Manufacturing, LLC-by Its Sole Member: Alo Acquisition LLCBarclays Bank, PLC as Collateral AgentFirst Lien Security Agreement
Sep 1, 2017
Reel 43746, frame 657
Albany Molecular Research, Inc.; Amri Burlington, Inc.; Cedarburg Pharmaceuticals, Inc.; Euticals Inc.; Oso Biopharmaceuticals Manufacturing LLC-by Its Sole Member:alo Acquisition LLCMorgan Stanley Senior Funding, Inc.Second Lien Security Agreement
Aug 14, 2018
Reel 46796, frame 352
Albany Molecular Research, Inc.; Alo Acquisition LLC; Amri Burlington, Inc.; Amri Rensselaer, Inc.; Cedarburg Pharmaceuticals, Inc.; Oso Biopharmaceuticals Manufacturing, LLCBarclays Bank PLC, as the Collateral AgentCorrective Assignment to Correct the Incorrect Patent No. 7541537 Previously Recorded at Reel: 034045 Frame: 0951. Assignor(S) Hereby Confirms the Security Interest.
Oct 29, 2020
Reel 54252, frame 687
Morgan Stanley Senior Funding, Inc., as Collateral AgentAlbany Molecular Research, Inc.; Amri Burlington, Inc.; Cedarburg Pharmaceuticals, Inc.; Euticals Inc.; Oso Biopharmaceuticals Manufacturing, LLCRelease of Security Interest
Oct 29, 2020
reel/frame not recorded
Morgan Stanley Senior Funding, Inc., as Collateral AgentAlbany Molecular Research, Inc.Release of Security Interest
Oct 29, 2020
reel/frame not recorded
Morgan Stanley Senior Funding, Inc., as Collateral AgentAmri Burlington, Inc.Release of Security Interest
Oct 29, 2020
reel/frame not recorded
Morgan Stanley Senior Funding, Inc., as Collateral AgentCedarburg Pharmaceuticals, Inc.Release of Security Interest
Oct 29, 2020
reel/frame not recorded
Morgan Stanley Senior Funding, Inc., as Collateral AgentEuticals Inc.Release of Security Interest
Oct 29, 2020
reel/frame not recorded
Morgan Stanley Senior Funding, Inc., as Collateral AgentOso Biopharmaceuticals Manufacturing, LLCRelease of Security Interest
Nov 16, 2020
Reel 54382, frame 326
Barclays Bank PLC, as Collateral AgentAlbany Molecular Research, Inc.Release of Security Interest
Mar 7, 2025
Reel 70442, frame 908
Curia Global, Inc.; Curia IP Holdings, LLC; Curia Bio, Inc.Apollo Administrative Agency LLCSecurity Interest
May 20, 2025
Reel 71298, frame 97
Albany Molecular Research, Inc.Curia Global, Inc.Change of Name
Jun 3, 2025
Reel 71490, frame 880
Apollo Administrative Agency LLCCuria Global, Inc.Partial Release of First Lien Intellectual Property Security Agreement Supplement

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited